Isolation and Identification of Phloroglucinol Derivatives from Dryopteris crassirhizoma by HPLC-LTQ-Orbitrap Mass Spectrometry
Isolation and Identification of Phloroglucinol Derivatives from Dryopteris crassirhizoma by HPLC-LTQ-Orbitrap Mass Spectrometry
复制标题
DOI:
10.1007/s10600-016-1887-x
复制
发表时间:
2016-11-01
影响因子:
0.8
通讯作者:
Wang, Hui-yun
中科院分区:
文献类型:
--
作者:
Ren, Qiang;Quan, Xian-gao;Wang, Hui-yun
Pharmacological investigations have demonstrated that D. crassirhizoma has a variety of pharmacological activities, such as antioxidant activity, determined by its 1, 1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging ability in vitro [1], and anticancer activity against human prostate cancer cells [2]. The hexane fraction of D. crassirhizoma, which contains flavaspidic acids AB and PB has antibacterial activity against methicillin-resistant Staphylococcus aureus [3, 4]. Flavaspidic acid AB can inhibit porcine reproductive and respiratory syndrome virus replication [5]. The acylphloroglucinol derivatives from the rhizomes of D. crassirhizoma have fatty acid synthase inhibitory activity [6]. In addition, the ethanol extract of D. crassirhizoma displays strong anti-inflammatory activity by suppressing ERK/AP-1 and TBK1/IRF3 pathways [7]. Previous phytochemical investigations revealed that D. crassirhizoma contains mainly phloroglucinol derivatives, triterpenoid, and flavonoids [8–12].The Dryopteris phloroglucinol derivatives consist of monomeric phlorophenone rings bridged by a methylene group. These homologues with an analogous composition and similar polarity were very difficult to separate in a pure state due to decomposition and reductive alkaline cleavage. Over the past decades, electron impact ionization [13], field-desorption ionization [14], and fast atom bombardment ionization [15] have been employed to elucidate the structures of phloroglucinol derivatives. However, there is not enough information about on-line characterization and identification of the phloroglucinol derivatives. The purpose of the present study was to identify the potential compounds responsible for the antileukemic activity of D. crassirhizoma Nakai. Firstly, a crude 95% aqueous ethanol extract of D. crassirhizoma Nakai was found to exhibit cytotoxic activity against human leukemic Reh cell lines. According to bioactivity-directed fractionation and isolation, fractions B and D were the most active fractions against Reh, which were further separated to yield flavaspidic acid AB (3), norflavaspidic acid AB (5), and 3-methylbutyrylphloroglucinol (6) together with three known compounds pentacosanol (1), 3-hydroxyheptacosanol (2), and E-sitosterol (4). Compound 6 was isolated from this plant for the first time. In addition, the phloroglucinol derivatives of D. crassirhizoma Nakai were characterized and identified by HPLC-LTQ-Orbitrap mass spectrometry. A total of 10 phloroglucinol derivatives was identified on the basis of accurate mass, multiple-stage mass data, and characteristic fragmentation patterns.